{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:31:20Z","timestamp":1787761880467,"version":"build-2784847793"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Breast cancer is the most prevalent malignancy in females which needs chemotherapy treatment. Studies demonstrated that anti-cancer agents used for chemotherapy in cancer patient causes endothelium dysfunction. Several researches showed the efficacy of angiotensin-converting enzyme inhibitors, Carvedilol and Spironolactone on improving endothelial function. This study aimed to evaluate the effect of the combination of Spironolactone, Carvedilol, and Captopril on endothelial function in breast cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This study is a prospective Randomized Clinical Trial in breast cancer patients who underwent chemotherapy. Patients were divided into two groups who received the combination of Captopril, Spironolactone, and Carvedilol or standard regimen for 3 months during chemotherapy. Before and after intervention, ejection fraction (EF), E\/A ratio and e' and flow-mediated dilation (FMD) properties were calculated and then compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Fifty-eight patients with a mean age of 47.57 \u00b1 9.46 years were evaluated. The mean FMD after the intervention is statistically different in case and controls (&lt;0.001). E\/A ratio and e' are not statistically different between groups after intervention. The mean EF was not statistically different between the two groups after intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Prescribing combination of Carvedilol, Spironolactone, and Captopril in breast cancer patients undergoing chemotherapy can improve endothelial function and may have beneficial effects on diastolic function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/abr.abr_81_21","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T05:48:23Z","timestamp":1684129703000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Comparative Evaluation of Captopril, Spironolactone, and Carvedilol Effect on Endothelial Function in Breast Cancer Women Undergoing Chemotherapy"],"prefix":"10.4103","volume":"12","author":[{"given":"Seyed Mohammad","family":"Hashemi Jazi","sequence":"first","affiliation":[{"name":"Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faranak","family":"Tayebi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Teimouri-Jervekani","sequence":"additional","affiliation":[{"name":"Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariborz","family":"Mokarian","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valiallah","family":"Mehrzad","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Sadeghi","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5]]},"reference":[{"key":"R1-20240830","first-page":"1147","article-title":"Endothelial dysfunction as a determinant of trastuzumab-mediated cardiotoxicity in patients with breast cancer","volume":"34","author":"Sandoo","year":"2014","journal-title":"Anticancer Res"},{"key":"R2-20240830","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7314\/APJCP.2014.15.1.433","article-title":"A single measure of cancer burden combining incidence with mortality rates for worldwide application","volume":"15","author":"Kim","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R3-20240830","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.canep.2012.02.007","article-title":"The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality","volume":"36","author":"Youlden","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"R4-20240830","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"R5-20240830","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/aje\/kws359","article-title":"Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: A nested case-control study","volume":"177","author":"Touvier","year":"2013","journal-title":"Am J Epidemiol"},{"key":"R6-20240830","doi-asserted-by":"crossref","first-page":"e44081","DOI":"10.1371\/journal.pone.0044081","article-title":"Nitric oxide synthase and breast cancer: Role of TIMP-1 in NO-mediated Akt activation","volume":"7","author":"Ridnour","year":"2012","journal-title":"PLoS One"},{"key":"R7-20240830","first-page":"3","article-title":"Breast cancer treatment and cardiovascular considerations","volume":"29","author":"Mehrpooya","year":"2018","journal-title":"Arch Breast Cancer"},{"key":"R8-20240830","first-page":"191","article-title":"The Effect of Anthracycline Chemotherapy on Arterial Stiffness","volume":"10","author":"TURAN","year":"2020","journal-title":"Sakarya T\u0131p Dergisi."},{"key":"R9-20240830","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.2147\/OTT.S126852","article-title":"Arterial stiffness in hematologic malignancies","volume":"10","author":"Mozos","year":"2017","journal-title":"Onco Targets Ther"},{"key":"R10-20240830","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejca.2018.07.006","article-title":"The 'Survivorship Passport' for childhood cancer survivors","volume":"102","author":"Haupt","year":"2018","journal-title":"Eur J Cancer"},{"key":"R11-20240830","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ejhf.196","article-title":"Protective effects of spironolactone against anthracycline-induced cardiomyopathy","volume":"17","author":"Akpek","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"R12-20240830","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jacc.2011.11.082","article-title":"Endothelial dysfunction, arterial stiffness, and heart failure","volume":"60","author":"Marti","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R13-20240830","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s40119-019-00150-w","article-title":"A review of the role of bradykinin and nitric oxide in the cardioprotective action of angiotensin-converting enzyme inhibitors: Focus on perindopril","volume":"8","author":"Ancion","year":"2019","journal-title":"Cardiol Ther"},{"key":"R14-20240830","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.3390\/ijms20133198","article-title":"Endothelial dysfunction in chronic heart failure: Assessment, findings, significance, and potential therapeutic targets","volume":"20","author":"Alem","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R15-20240830","doi-asserted-by":"crossref","first-page":"461","DOI":"10.21037\/atm.2018.11.16","article-title":"Role of spironolactone in the treatment of heart failure with preserved ejection fraction","volume":"6","author":"Kosmas","year":"2018","journal-title":"Ann Transl Med"},{"key":"R16-20240830","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4103\/ijmr.IJMR_1323_14","article-title":"Preventive role of carvedilol in adriamycin-induced cardiomyopathy","volume":"144","author":"Jhorawat","year":"2016","journal-title":"Indian J Med Res"},{"key":"R17-20240830","doi-asserted-by":"crossref","first-page":"11293","DOI":"10.1021\/bi971475e","article-title":"Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin","volume":"36","author":"V\u00e1squez-Vivar","year":"1997","journal-title":"Biochemistry"},{"key":"R18-20240830","doi-asserted-by":"crossref","first-page":"47266","DOI":"10.1074\/jbc.M106829200","article-title":"Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. Effect of antiapoptotic antioxidants and calcium","volume":"276","author":"Kalivendi","year":"2001","journal-title":"J Biol Chem"},{"key":"R19-20240830","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1006\/jmcc.2002.2110","article-title":"Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: In vitro and in vivo studies","volume":"34","author":"Wu","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"R20-20240830","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3345\/kjp.2013.56.3.130","article-title":"Vascular endothelial dysfunction after anthracyclines treatment in children with acute lymphoblastic leukemia","volume":"56","author":"Jang","year":"2013","journal-title":"Korean J Pediatr"},{"key":"R21-20240830","first-page":"453264","article-title":"The effect of antihypertensive drugs on endothelial function as assessed by flow-mediated vasodilation in hypertensive patients","volume":"2012","author":"Miyamoto","year":"2012","journal-title":"Int J Vasc Med"},{"key":"R22-20240830","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2174\/1874192401004010302","article-title":"The endothelium and its role in regulating vascular tone","volume":"4","author":"Sandoo","year":"2010","journal-title":"Open Cardiovasc Med J"},{"key":"R24-20240830","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/met.2019.0099","article-title":"Metabolic and cardiovascular effects of switching thiazides to amlodipine in hypertensive patients with and without type 2 diabetes (the Diuretics and Diabetes Control Study)","volume":"18","author":"Buscemi","year":"2020","journal-title":"Metab Syndr Relat Disord"},{"key":"R26-20240830","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1021\/acs.jmedchem.9b01780","article-title":"The other angiotensin II receptor: AT2R as a therapeutic target","volume":"63","author":"Juillerat-Jeanneret","year":"2020","journal-title":"J Med Chem"},{"key":"R27-20240830","doi-asserted-by":"crossref","first-page":"19719","DOI":"10.1038\/s41598-019-56263-8","article-title":"Associations of ACE I\/D polymorphism with the levels of ACE, kallikrein, angiotensin II and interleukin-6 in STEMI patients","volume":"9","author":"Dai","year":"2019","journal-title":"Sci Rep"},{"key":"R28-20240830","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3317\/jraas.2003.032","article-title":"Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients","volume":"4","author":"Yavuz","year":"2003","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"R29-20240830","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.2337\/diacare.27.7.1712","article-title":"Quinapril, an ACE inhibitor, reduces markers of oxidative stress in the metabolic syndrome","volume":"27","author":"Khan","year":"2004","journal-title":"Diabetes Care"},{"key":"R30-20240830","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.amjhyper.2007.01.019","article-title":"Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus","volume":"20","author":"Bank","year":"2007","journal-title":"Am J Hypertens"},{"key":"R31-20240830","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jdiacomp.2007.05.003","article-title":"Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension","volume":"22","author":"Jawa","year":"2008","journal-title":"J Diabetes Complications"},{"key":"R32-20240830","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/ajh.2008.260","article-title":"Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients","volume":"21","author":"Pasini","year":"2008","journal-title":"Am J Hypertens"},{"key":"R33-20240830","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/cvr\/cvaa006","article-title":"Treatment of coronary microvascular dysfunction","volume":"116","author":"Bairey Merz","year":"2020","journal-title":"Cardiovasc Res"},{"key":"R34-20240830","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3389\/fendo.2019.00584","article-title":"Role of aldosterone and mineralocorticoid receptor in cardiovascular aging","volume":"10","author":"Gorini","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R35-20240830","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1097\/HJH.0000000000002524","article-title":"Repeated administration of inorganic nitrate on blood pressure and arterial stiffness: A systematic review and meta-analysis of randomized controlled trials","volume":"38","author":"Li","year":"2020","journal-title":"J Hypertens"},{"key":"R36-20240830","doi-asserted-by":"crossref","first-page":"102063","DOI":"10.1016\/j.nano.2019.102063","article-title":"Polyethylenimine-coated superparamagnetic iron oxide nanoparticles impair in vitro and in vivo angiogenesis","volume":"21","author":"Mulens-Arias","year":"2019","journal-title":"Nanomedicine"},{"key":"R37-20240830","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1016\/j.transproceed.2008.06.038","article-title":"Endothelial injury, an intriguing effect of methotrexate and cyclophosphamide during hematopoietic stem cell transplantation in mice","volume":"40","author":"Zeng","year":"2008","journal-title":"Transplant Proc"},{"key":"R38-20240830","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.freeradbiomed.2012.02.003","article-title":"Activation of p38 MAPK by oxidative stress underlying epirubicin-induced vascular endothelial cell injury","volume":"52","author":"Yamada","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"R39-20240830","first-page":"50","article-title":"Left ventricular regional wall motion abnormality is a strong predictor of cardiotoxicity in breast cancer patients undergoing chemotherapy","volume":"112","author":"de Barros","year":"2019","journal-title":"Arq Bras Cardiol"},{"issue":"Suppl 5","key":"R40-20240830","doi-asserted-by":"crossref","first-page":"v277","DOI":"10.1093\/annonc\/mdq200","article-title":"Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines","volume":"21","author":"Bovelli","year":"2010","journal-title":"Ann Oncol"},{"key":"R41-20240830","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejheart.2004.02.003","article-title":"Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC)","volume":"6","author":"Bergstr\u00f6m","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"R42-20240830","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2013.02.072","article-title":"Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: The OVERCOME trial (prevention of left ventricular dysfunction with Enalapril and carvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies)","volume":"61","author":"Bosch","year":"2013","journal-title":"J Am Coll Cardiol"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_81_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:07:04Z","timestamp":1787760424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_81_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/abr.abr_81_21","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"2021-04-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}